Search Within

Brian Ernest Serencsits

Formats
  1. Journal Article (6)
  2. Meeting Abstract (5)
Groups
  1. Radiology, Department of (8)
  2. Medical Physics (7)
  3. Molecular Imaging and Therapy Service (7)
  4. Sloan Kettering Institute Postdocs (3)
  5. Advanced Practice Providers (2)
  6. Neuro-Oncology Service (2)

More Groups

People
  1. Neeta Pandit-Taskar (7)
  2. Lawrence Dauer (6)
  3. Bae Chu (5)
  4. Kavya Prasad (4)
  5. Brian Quinn (2)
  6. Daniel Miodownik (2)

More People

Years
  1. 2024 (4)
  2. 2023 (4)
  3. 2022 (2)
  4. 2019 (1)
Publications
  1. Journal of Nuclear Medicine (3)
  2. European Journal of Nuclear Medicine and Molecular Imaging (2)
  3. EJNMMI Research (1)
  4. Journal of Nuclear Medicine Technology (1)
  5. Journal of Radiological Protection (1)
  6. Journal of Vascular and Interventional Radiology (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (3)
  2. Springer (3)
  3. Elsevier Inc. (1)
  4. Elsevier Science, Inc. (1)
  5. IOP Publishing Ltd (1)
  6. Oxford University Press (1)

More Publishers

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mathematical modeling of exposure measurements following high-dose targeted therapy using 131I-apamistamab: Analysis from the large multicenter phase III SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Chen, L. Y.; Serencsits, B.; Prasad, K.; Senglaub, T.; Zgaljardic, M.; Spross, J.; Desai, A.; Brodin, P.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Modeling-based assessment of exposure measurements after high-dose targeted (131)I-apamistamab: Results and analyses from the phase III SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Chen, L.; Serencsits, B.; Prasad, K.; Senglaub, T.; Zgaljardic, M.; Spross, J.; Desai, A.; Brodin, P.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Theranostic intratumoral convection-enhanced delivery of (124)I-omburtamab in patients with diffuse intrinsic pontine glioma: Pharmacokinetics and lesion dosimetry
    Journal Article

    Pandit-Taskar, N.; Zanzonico, P. B.; Grkovski, M.; Donzelli, M.; Vietri, S. M.; Horan, C.; Serencsits, B.; Prasad, K.; Lyashchenko, S.; Kramer, K.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with (131)I-omburtamab for leptomeningeal disease
    Journal Article

    Prasad, K.; Serencsits, B. E.; Chu, B. P.; Dauer, L. T.; Donzelli, M.; Basu, E.; Kramer, K.; Pandit-Taskar, N.
    EJNMMI Research (2024)

    Fulltext@MSK | Save
  • Administration and radiation safety of high-dose Iomab-B (I131-apamistamab) demonstrated in multiple clinical settings: Experience from the large multicenter phase 3 SIERRA trial for targeted conditioning of patients with relapsed/refractory AML
    Meeting Abstract

    Serencsits, B.; Prasad, K.; Chen, L.; Senglaub, T.; Zgaljardic, M.; Brodin, P.; McNamara, K.; Desai, A.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Feasibility of high- dose targeted radiation with I131apamistamab in patients with relapsed/refractory AML: Dosimetry and radiation safety experience from the phase 3 SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Prasad, K.; Chen, L.; Senglaub, T.; Zgaljardic, M.; Brodin, P.; Serencsits, B.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Yttrium-90 activity quantification in PET/CT–guided biopsy specimens from colorectal hepatic metastases immediately after transarterial radioembolization using micro–CT and autoradiography
    Journal Article

    Naydenov, N.; Teplov, A.; Zirakchian, M. Z.; Ruan, S.; Chu, B. P.; Serencsits, B.; Iraca, M.; Talarico, O.; Miller, B.; Kunin, H.; more...
    Journal of Vascular and Interventional Radiology (2023)

    Fulltext@MSK | Save
  • Impact of shield location on staff and caregiver dose rates for I-131 radiopharmaceutical therapy patients
    Journal Article

    Bellamy, M.; Chu, B.; Serencsits, B.; Quinn, B.; Prasad, K.; Altamirano, J.; Williamson, M.; Miodownik, D.; Abrahams, N.; Chen, F.; more...
    Journal of Radiological Protection (2023)

    Fulltext@MSK | Save
  • Substantial external dose rate variability observed in a cohort of Lu-177 patients independent of BMI and sex
    Journal Article

    Bellamy, M.; Chu, B.; Serencsits, B.; Quinn, B.; Prasad, K.; Altamirano, J.; Williamson, M.; Miodownik, D.; Abrahams, N.; Chen, F.; more...
    Radiation Protection Dosimetry (2022)

    Fulltext@MSK | Save
  • Radiation safety considerations and clinical advantages of alpha-emitting therapy radionuclides
    Journal Article

    Serencsits, B.; Chu, B. P.; Pandit-Taskar, N.; McDevitt, M. R.; Dauer, L. T.
    Journal of Nuclear Medicine Technology (2022)

    Fulltext@MSK | Save